Growing community of inventors

Busan, South Korea

Dong Sik Park

Average Co-Inventor Count = 9.34

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 23

Dong Sik ParkHwan Mook Kim (2 patents)Dong Sik ParkHwan Geun Choi (2 patents)Dong Sik ParkTae Bo Sim (2 patents)Dong Sik ParkYoung Jin Ham (2 patents)Dong Sik ParkJung Mi Hah (2 patents)Dong Sik ParkKyung Ho Yoo (1 patent)Dong Sik ParkJung Beom Son (1 patent)Dong Sik ParkChang Hyun Oh (1 patent)Dong Sik ParkSung Yun Cho (1 patent)Dong Sik ParkJae Du Ha (1 patent)Dong Sik ParkDong Cho Han (1 patent)Dong Sik ParkByoung Mog Kwon (1 patent)Dong Sik ParkSo Ha Lee (1 patent)Dong Sik ParkJung Hun Lee (1 patent)Dong Sik ParkDong Sik Park (2 patents)Hwan Mook KimHwan Mook Kim (82 patents)Hwan Geun ChoiHwan Geun Choi (51 patents)Tae Bo SimTae Bo Sim (21 patents)Young Jin HamYoung Jin Ham (13 patents)Jung Mi HahJung Mi Hah (8 patents)Kyung Ho YooKyung Ho Yoo (27 patents)Jung Beom SonJung Beom Son (16 patents)Chang Hyun OhChang Hyun Oh (16 patents)Sung Yun ChoSung Yun Cho (14 patents)Jae Du HaJae Du Ha (10 patents)Dong Cho HanDong Cho Han (10 patents)Byoung Mog KwonByoung Mog Kwon (6 patents)So Ha LeeSo Ha Lee (4 patents)Jung Hun LeeJung Hun Lee (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Korea Institute of Science and Technology (2 from 2,164 patents)

2. Korea Research Institute of Chemical Technology (1 from 623 patents)

3. Korea Research Institute of Bioscience and Biotechnology (1 from 321 patents)


2 patents:

1. 9422307 - 2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors

2. 8754209 - Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…